Suzanne E. Dahlberg

14.9k total citations · 4 hit papers
150 papers, 9.3k citations indexed

About

Suzanne E. Dahlberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Suzanne E. Dahlberg has authored 150 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Suzanne E. Dahlberg's work include Lung Cancer Treatments and Mutations (76 papers), Lung Cancer Research Studies (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Suzanne E. Dahlberg is often cited by papers focused on Lung Cancer Treatments and Mutations (76 papers), Lung Cancer Research Studies (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Suzanne E. Dahlberg collaborates with scholars based in United States, Canada and Israel. Suzanne E. Dahlberg's co-authors include Pasi A. Jänne, Geoffrey R. Oxnard, Joan H. Schiller, David M. Jackman, Lynette M. Sholl, Lewis B. Silverman, Stephen E. Sallan, Bruce E. Johnson, Mark M. Awad and Mizuki Nishino and has published in prestigious journals such as Circulation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Suzanne E. Dahlberg

142 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

2018 513 citations Geoffrey R. Oxnard, Daniel B. Costa et al. profile →
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

2016 493 citations Geoffrey R. Oxnard, David M. Jackman et al. Journal of Clinical Oncology profile →
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer

2016 432 citations Cloud P. Paweletz, Suzanne E. Dahlberg et al. profile →
Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

2015 348 citations Deepa Rangachari, Suzanne E. Dahlberg et al. profile →

Peers

Countries citing papers authored by Suzanne E. Dahlberg

Since Specialization

Citations

This map shows the geographic impact of Suzanne E. Dahlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Dahlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Dahlberg more than expected).

Fields of papers citing papers by Suzanne E. Dahlberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Dahlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Dahlberg. The network helps show where Suzanne E. Dahlberg may publish in the future.

Co-authorship network of co-authors of Suzanne E. Dahlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Dahlberg. A scholar is included among the top collaborators of Suzanne E. Dahlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Dahlberg. Suzanne E. Dahlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pediatric Palliative Care Consultation in the PICU Following Out-of-Hospital Cardiac Arrest: Analysis of the U.S. Pediatric Health Information Systems Database, 2013–2023 2025 ·Pediatric Critical Care Medicine ·(unknown), Jennifer M. Snaman, Rosario D’Anna, (unknown), Suzanne E. Dahlberg, Abby R. Rosenberg, Danielle D. DeCourcey	0
2	Impact of Social Determinants on Home Oxygen Therapy Duration in Preterm Infants: A Study Utilizing the Childhood Opportunity Index 2025 ·Pediatric Pulmonology ·(unknown), (unknown), Suzanne E. Dahlberg, (unknown), Amit Agarwal, (unknown), Catherine A. Sheils, Lawrence Rhein, Jonathan C. Levin	0
3	Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes 2024 ·Pediatric Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), Suzanne E. Dahlberg, Rachel Rosen, Gary Visner	1
4	Virtual interviews and equity: The pediatric pulmonary fellow perspective 2024 ·Pediatric Pulmonology ·(unknown), Laura Chiel, Traci M. Kazmerski, (unknown), (unknown), Robyn T. Cohen, Theresa A. Laguna, (unknown), Suzanne E. Dahlberg, (unknown), Alicia Casey	0
5	Comparison of Pneumotachometer and Portable Digital Turbine Spirometry for Field-Based Assessment: An Air Quality, Environment, and Respiratory Outcomes in Bronchopulmonary Dysplasia Study 2023 ·Pediatric Allergy Immunology and Pulmonology ·(unknown), (unknown), Lystra P. Hayden, Suzanne E. Dahlberg, Jonathan M. Gaffin	1
6	Eating disorders in adolescents and young adults with cystic fibrosis 2022 ·Pediatric Pulmonology ·(unknown), Laura Berbert, Suzanne E. Dahlberg, Elana M. Bern, Sabina Sabharwal, (unknown), Tracy K. Richmond, G. Sawicki	7
7	Real‐world feasibility of short‐term, unsupervised home spirometry in CF 2022 ·Pediatric Pulmonology ·(unknown), (unknown), (unknown), Suzanne E. Dahlberg, (unknown), (unknown), Ravneet Kaur, (unknown), G. Sawicki	16
8	Attitudes towards involving children in decision‐making surrounding lung transplantation 2021 ·Pediatric Pulmonology ·(unknown), (unknown), Suzanne E. Dahlberg, Robert D. Truog	2
9	Peer-to-Peer Social Media Communication About Dietary Supplements Used for Weight Loss and Sports Performance Among Military Personnel: Pilot Content Analysis of 11 Years of Posts on Reddit 2021 ·JMIR Formative Research ·(unknown), (unknown), Elissa R. Weitzman, (unknown), Suzanne E. Dahlberg, S. Bryn Austin	5
10	Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non–Small Cell Lung Cancer 2020 ·Clinical Cancer Research ·Alissa J. Cooper, Yoshihisa Kobayashi, Dewey Kim, (unknown), Sasha Kravets, Suzanne E. Dahlberg, Emily S. Chambers, Jiaqi Li, Deepa Rangachari, Tom Nguyen, Daniel B. Costa, Michael S. Rabin, Nikhil Wagle, Lynette M. Sholl, Pasi A. Jänne, Geoffrey R. Oxnard	14
11	Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor 2019 ·Cancer Discovery ·Ciric To, Jaebong Jang, Ting Chen, Eunyoung Park, Mierzhati Mushajiang, Dries J.H. De Clercq, Man Xu, Stephen Wang, Michael D. Cameron, David E. Heppner, Bo Hee Shin, Thomas W. Gero, Annan Yang, Suzanne E. Dahlberg, Kwok‐Kin Wong, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne	250
12	Cytologic‐histologic correlation of programmed death‐ligand 1 immunohistochemistry in lung carcinomas 2018 ·Cancer Cytopathology ·Eleanor Russell‐Goldman, Sasha Kravets, Suzanne E. Dahlberg, Lynette M. Sholl, Marina Vivero	66
13	Clinical and Molecular Characteristics of NF1 -Mutant Lung Cancer 2016 ·Clinical Cancer Research ·Amanda J. Redig, Marzia Capelletti, Suzanne E. Dahlberg, Lynette M. Sholl, Stacy L. Mach, (unknown), Yunling Shi, Poornima Chalasani, Pasi A. Jänne	53
14	A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR -Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial 2016 ·Clinical Cancer Research ·Masahiko Yanagita, Amanda J. Redig, Cloud P. Paweletz, Suzanne E. Dahlberg, Allison O’Connell, Nora Feeney, Myriam Taibi, David Boucher, Geoffrey R. Oxnard, Bruce E. Johnson, Daniel B. Costa, David M. Jackman, Pasi A. Jänne	92
15	Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma 2015 ·Clinical Cancer Research ·Antonio Calles, Lynette M. Sholl, Scott J. Rodig, Ashley K. Pelton, Jason L. Hornick, Mohit Butaney, Christine Lydon, Suzanne E. Dahlberg, Geoffrey R. Oxnard, David M. Jackman, Pasi A. Jänne	86
16	Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 2013 ·Journal of Clinical Oncology ·Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Jane O’Brien, Suzanne E. Dahlberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Jeffery L. Kutok, Caroline Laverdière, Steven E. Lipshultz, Bruno Michon, Marshall A. Schorin, Mary V. Relling, Harvey J. Cohen, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman	227
17	Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes 2012 ·Journal of Clinical Oncology ·Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Stuart R. Lipsitz, Nader Rifai, Lewis B. Silverman, Steven D. Colan, Donna Neuberg, Suzanne E. Dahlberg, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Stephen E. Sallan	227
18	Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation 2011 ·Cancer Discovery ·Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Jeffery L. Kutok, Janina A. Longtine, Frank C. Kuo, Terry Haley, (unknown), Timothy J. Sullivan, David C. Fisher, Edward A. Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock	64
19	Absence of Biallelic TCR γ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia 2010 ·Journal of Clinical Oncology ·Alejandro Gutiérrez, Suzanne E. Dahlberg, Donna Neuberg, Jianhua Zhang, Ruta Grebliunaite, Takaomi Sanda, Alexei Protopopov, Valeria Tosello, Jeffery L. Kutok, Richard A. Larson, Michael J. Borowitz, Mignon L. Loh, Adolfo A. Ferrando, Stuart S. Winter, Charles G. Mullighan, Lewis B. Silverman, Lynda Chin, Stephen P. Hunger, Stephen E. Sallan, A. Thomas Look	69
20	Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 2007 ·Journal of Clinical Oncology ·Suresh S. Ramalingam, Suzanne E. Dahlberg, Corey J. Langer, Robert J. Gray, Chandra P. Belani, Julie R. Brahmer, Alan B. Sandler, Joan H. Schiller, David H. Johnson	251

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact